Yakov Kogan

Chief Executive Officer at

Panacela Labs, Inc.

52 year

50 connections

Health Technology

Commercial Services

Consumer Services

Profile

Yakov Kogan was the founder of Cleveland BioLabs, Inc. (founded in 2003, titles: Chief Executive & Financial Officer, Secretary) and Statera Biopharma, Inc. (founded in 2003, title: Senior Vice President-Strategy & Alliance).
Current jobs include Chief Executive Officer at Panacela Labs, Inc. (since 2011), Director & Principal Business Officer at Kadvax Technologies, Inc. (job end: null), and Chief Operations Officer at Genome Protection, Inc. (job end: null).
Former jobs include Director-Business Development at Integrated Genomics, Inc. (2002-2003), Director at Incuron LLC, Director at Quad M Solutions, Inc. (2022), Senior Scientist at ThermoGen, Inc., and Research Associate at The University of Chicago.
Education includes an MBA from The University of Chicago, a graduate degree from Moscow State University Lomonosov, and a doctorate from VNII Ekonomiki Selskogo Khozaystva.

Yakov Kogan active positions

Companies	Position	Start
Panacela Labs, Inc. Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs against cancer	Chief Executive Officer	-
Kadvax Technologies, Inc. Kadvax Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research services	Director/Board Member	-
Genome Protection, Inc. Genome Protection, Inc. Miscellaneous Commercial ServicesCommercial Services Genome Protection, Inc. is a clinical-stage biopharmaceutical company focused on developing medical interventions to prevent and treat aging and age-related diseases. The company is based in Buffalo, NY. The company’s technologies are based on insights into mechanisms leading to genomic instability, impairment of immunity, and systemic inflammation in aging. Genome Protection develops drugs, including TLR5 agonists entolimod and GP532, that are projected to improve immune functions in the elderly. The company also applies its research and development capabilities to create a pipeline of small-molecule and immunotherapeutic drug candidates targeting mechanisms underlying genomic instability in somatic tissues during aging and cancer progression, driven by endogenous retroelements.	Chief Operating Officer	-

All active positions of Yakov Kogan

Former positions of Yakov Kogan

Companies	Position	End
STATERA BIOPHARMA, INC.	Chief Executive Officer	2019-12-12
Integrated Genomics, Inc. Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides bioinformatics products to support research in microbial genomics, biochemistry and gene expression	Corporate Officer/Principal	2002-12-31
QUAD M SOLUTIONS, INC.	Chief Operating Officer	-
STATERA BIOPHARMA, INC.	Founder	-
Incuron LLC Incuron LLC Pharmaceuticals: MajorHealth Technology Develops anticancer drugs	Director/Board Member	-

See the detail of Yakov Kogan's experience

Training of Yakov Kogan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yakov Kogan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
Quad M Solutions, Inc. Quad M Solutions, Inc. Personnel ServicesCommercial Services Operates as a holding company whose subsidiaries provides staffing and business consulting services	Commercial Services
Cleveland BioLabs, Inc. Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to activate the immune system and address serious medical needs	Health Technology
Panacela Labs, Inc. Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs against cancer	Health Technology
Integrated Genomics, Inc. Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides bioinformatics products to support research in microbial genomics, biochemistry and gene expression	Commercial Services
ThermoGen, Inc. ThermoGen, Inc. Medical SpecialtiesHealth Technology Develops biocatalysts for pharmaceutical production	Health Technology
The University of Chicago The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Moscow State University Lomonosov Moscow State University Lomonosov Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Incuron LLC Incuron LLC Pharmaceuticals: MajorHealth Technology Develops anticancer drugs	Health Technology
VNII Ekonomiki Selskogo Khozaystva VNII Ekonomiki Selskogo Khozaystva Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kadvax Technologies, Inc. Kadvax Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research services	Commercial Services
Genome Protection, Inc. Genome Protection, Inc. Miscellaneous Commercial ServicesCommercial Services Genome Protection, Inc. is a clinical-stage biopharmaceutical company focused on developing medical interventions to prevent and treat aging and age-related diseases. The company is based in Buffalo, NY. The company’s technologies are based on insights into mechanisms leading to genomic instability, impairment of immunity, and systemic inflammation in aging. Genome Protection develops drugs, including TLR5 agonists entolimod and GP532, that are projected to improve immune functions in the elderly. The company also applies its research and development capabilities to create a pipeline of small-molecule and immunotherapeutic drug candidates targeting mechanisms underlying genomic instability in somatic tissues during aging and cancer progression, driven by endogenous retroelements.	Commercial Services
Statera Biopharma, Inc. Statera Biopharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies	Health Technology